SEC Form 4 · accession 0001209191-16-090356
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopherd T Guiffre
Officer — Chief Executive Officer · Director
Period of report
Jan 5, 2016
Accepted (ET)
Jan 7, 2016 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $3.04 | Jan 5, 2016 | A | 137,000 | A | — | Jan 4, 2026 | Common Stock | 137,000 | 137,000 | D |
Explanation of responses
- F1This option was granted on January 5, 2016. The option vests in 48 equal monthly installments over the four year period following the date of grant.